SHEA SIMS: Open Payments
NPI 1730677675 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 50 payments from 20 companies in 2025. Trend: 2023 $176 · 2024 $558 · 2025 $1,241
Food & beverage: $1,066Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $413 |
| UCB, Inc. | 3 | $166 |
| ABBVIE INC. | 10 | $150 |
| SCILEX PHARMACEUTICALS INC. | 1 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Insulet Corporation | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Sequel Med Tech, LLC | 2 | $43 |
| Genentech USA, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
Products named: PROLIA, Bimzelx, EVENITY, ENBREL, UBRELVY, ZTLido, Kerendia, Omnipod.
Industry payments across AR — which companies pay providers there.
